WHO Asks Bharat Biotech For More Info on Covaxin : vimarsana.com

The World Health Organization's technical advisory group requested "further clarifications" from Bharat Biotech for its COVID-19 vaccine ‘Covaxin’ on Tuesday in order to complete a final risk-benefit analysis for the vaccine's Emergency Use Listing. For a final review, the technical advisory panel will convene on November 3rd. On Tuesday, the technical advisory panel convened

Related Keywords

India , Bharat , , World Health Organization , Technical Advisory Group For Emergency Use Listing , Bharat Biotech , Emergency Use , Hyderabad Based Bharat Biotech , Emergency Use Listing , Technical Advisory Group , Covaxin , Covaxin Who Approval , Bharat Biotech Covaxin Approval , Harat Biotech Covaxin Who Approval , Who Covaxin Approval , Ho Covaxin Bharat Biotech Approval ,